| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |